1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
    Neuronal Signaling
  3. Calcium Channel
  4. Calcium Channel Inhibitors

Calcium Channel Inhibitors

N-type calcium channel

L-type calcium channel

P/Q-type calcium channel

T-type calcium channel

Calcium Channel

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Calcium Channel Inhibitors, Agonists, Antagonists, Activators, Modulators & Controls
Product Name N-type calcium channel L-type calcium channel P/Q-type calcium channel T-type calcium channel Calcium Channel Purity
L-Ascorbic acid      
T-type calcium channel
  99.97%
Minocycline hydrochloride  
L-type calcium channel
      99.71%
L-Ascorbic acid sodium salt      
T-type calcium channel
  99.97%
Bay K 8644  
L-type calcium channel, EC50: 17.3 nM
      99.96%
Ruthenium red  
L-type calcium channel
      99.95%
Amlodipine  
L-type calcium channel
      99.87%
Ethacrynic acid  
L-type calcium channel
      99.98%
Nisoldipine  
L-type calcium channel
      99.56%
Isradipine  
L-type calcium channel
      99.97%
Diltiazem  
L-type calcium channel
      99.70%
NNC 55-0396      
T-type calcium channel
  98.43%
Flufenamic acid  
L-type calcium channel
      99.93%
Cilnidipine  
L-type calcium channel
      99.89%
Felodipine  
L-type calcium channel
      99.83%
Diltiazem hydrochloride  
L-type calcium channel
      99.47%
Urolithin C  
L-type calcium channel
      98.00%
(S)-(-)-Bay-K-8644  
L-type calcium channel
      99.22%
Ziconotide acetate
N-type calcium channel
        99.23%
Manidipine dihydrochloride      
T-type calcium channel
  99.84%
Ginsenoside Rd  
L-type calcium channel
      99.88%
Ethosuximide      
T-type calcium channel
  99.35%
Fluspirilene  
L-type calcium channel
      99.66%
Trimethadione      
T-type calcium channel
  99.59%
Diacerein  
L-type calcium channel
      99.42%
Ulixacaltamide      
T-type calcium channel
  98.73%
Amlodipine besylate  
L-type calcium channel
      99.72%
Mibefradil dihydrochloride  
L-type calcium channel
 
T-type calcium channel
  99.71%
Minocycline  
L-type calcium channel
      98.59%
5-Hydroxyindole  
L-type calcium channel
      99.94%
ω-Agatoxin IVA TFA    
P/Q-type calcium channel
    99.52%
Ginsenoside Rf
N-type calcium channel
        99.48%
Lacidipine  
L-type calcium channel
      99.40%
Dronedarone  
L-type calcium channel
      99.93%
Flunarizine dihydrochloride      
T-type calcium channel
  99.90%
Plantainoside D        
Calcium Channel
99.15%
TTA-A2      
T-type calcium channel
  99.33%
Pinaverium bromide  
L-type calcium channel
      99.73%
Azelnidipine  
L-type calcium channel
      99.79%
(R)-(+)-Bay-K-8644  
L-type calcium channel
      99.36%
TTA-P2      
T-type calcium channel
Cav3.2
  99.58%
1-Octanol      
T-type calcium channel
  99.63%
Norfluoxetine hydrochloride      
CaV3.3, IC50: 5 μM
  99.58%
ML218      
T-type calcium channel
  99.49%
CaV1.3 antagonist-1  
CaV1.3, IC50: 1.7 μM
      98.38%
Lomerizine dihydrochloride  
L-type calcium channel
 
T-type calcium channel
  99.95%
Suvecaltamide      
T-type calcium channel
  99.96%
Etripamil  
L-type calcium channel
      98.10%
SAK3      
T-type calcium channel
  99.80%
Catharanthine  
L-type calcium channel
      99.65%
Nefiracetam
N-type calcium channel
L-type calcium channel
      99.87%
Norverapamil hydrochloride  
L-type calcium channel
      99.80%
Efonidipine hydrochloride monoethanolate  
L-type calcium channel, IC50: 1.8 nM
 
T-type calcium channel, IC50: 350 nM
  99.83%
Ethacrynic acid (Standard)  
L-type calcium channel
     
Aladorian        
Calcium Channel
99.55%
Trimebutine  
L-type calcium channel
      99.42%
Apinocaltamide  
Cav1.2, IC50: 2410 nM
 
CaV3.1, IC50: 6.4 nM
Cav3.2, IC50: 18 nM
CaV3.3, IC50: 7.5 nM
  99.83%
Hirudin (54-65)  
L-type calcium channel
      99.20%
Barnidipine hydrochloride  
L-type calcium channel
      99.94%
(2R,3R)-Butane-2,3-diol        
La3+-sensitive calcium channel, EC50: 25 mM
99.69%
GV-58
N-type calcium channel, EC50: 7.21 μM
 
P/Q-type calcium channel, EC50: 8.81 μM
    99.22%
Levamlodipine  
L-type calcium channel
      98.06%
Trimebutine maleate  
L-type calcium channel
      99.66%
MMK1        
Calcium Channel
99.71%
Amlodipine maleate  
L-type calcium channel
      99.87%
Landiolol hydrochloride  
L-type calcium channel
      99.96%
Azimilide dihydrochloride  
L-type calcium channel, IC50: 17.8 μM
      98.17%
TROX-1
CaV2.2, IC50: 0.11 μM
        99.55%
Flavoxate hydrochloride  
L-type calcium channel
      99.70%
NP118809
N-type calcium channel, IC50: 0.11 μM
L-type calcium channel, IC50: 12.2 μM
      98.73%
Azimilide  
L-type calcium channel, IC50: 17.8 μM
      99.01%
SR33805  
L-type calcium channel, EC50: 4.1 nM (in depolarized conditions)
L-type calcium channel, EC50: 33 nM (in polarized conditions)
      99.78%
(R)-Nimodipine  
L-type calcium channel, IC50: 5 nM
      99.87%
Efonidipine  
L-type calcium channel, IC50: 1.8 nM
 
T-type calcium channel, IC50: 350 nM
  99.88%
ABT-639      
T-type calcium channel
  99.32%
Drotaverine hydrochloride  
L-type calcium channel
      99.65%
IDO1-IN-19        
ICa, IC50: 8.3 μM
98.82%
ω-Agatoxin IVA    
P/Q-type calcium channel
    98.71%
Ca2+ channel agonist 1
N-type calcium channel, EC50: 14.23 μM
        98.87%
(2R/S)-6-PNG      
T-type calcium channel
  99.96%
TTA-Q6(isomer)      
T-type calcium channel
  99.91%
ω-Agatoxin TK    
P/Q-type calcium channel
    ≥99.0%
Cycleanine  
L-type calcium channel
      99.80%
Psoralenoside  
L-type calcium channel
      99.84%
Cav 2.2 blocker 2
N-type calcium channel
        98.51%
VU6032735  
L-type calcium channel
      99.26%
ProTx-I      
T-type calcium channel
 
N-Desalkylflurazepam  
Cav1.2, IC50: 55 μM
CaV1.3, IC50: 37 μM
      99.95%
MONIRO-1
hCav2.2, IC50: 34 μM
   
hCav3.1, IC50: 3.3 μM
hCav3.2, IC50: 1.7 μM
hCav3.3, IC50: 7.2 μM
  99.18%
(2R,3R)-Butane-2,3-diol (Standard)        
La3+-sensitive calcium channel, EC50: 25 mM
NS-638  
L-type calcium channel
      99.84%
Barnidipine  
L-type calcium channel
     
Catharanthine Tartrate  
L-type calcium channel
      98.88%
CXL-1020  
L-type calcium channel
      ≥99.0%
Catharanthine Sulfate  
L-type calcium channel
     
TTA-Q6      
T-type calcium channel
  99.97%
ILS-920  
L-type calcium channel
      99.9%
N-Salicyloyltryptamine  
L-type calcium channel
     
cis-Ned19        
Calcium Channel
99.25%
Barnidipine-d5 hydrochloride  
L-type calcium channel
      98.9%
Amlodipine-d4 maleate  
L-type calcium channel
      98.19%
Mibefradil  
L-type calcium channel
 
T-type calcium channel
 
PD0176078
N-type calcium channel
        99.80%
Ziconotide
N-type calcium channel
       
Ziconotide TFA
N-type calcium channel
       
Amlodipine mesylate  
L-type calcium channel
     
Mibefradil dihydrochloride hydrate  
L-type calcium channel
     
IAA65      
T-type calcium channel
 
RCC-36 hydrochloride  
L-type calcium channel
     
MMK1 TFA        
Calcium Channel
BTT-369
CaV2.2, IC50: 31 μM
       
IAB15      
T-type calcium channel
 
PAM-2
CaV2.2, IC50: 89 μM
       
Calcium Channel antagonist 6
CaV2.2
       
Multitarget AD-IN-4        
Calcium Channel, IC50: 30.59 μM
Ethacrynic acid D5  
L-type calcium channel
     
Onychocin B  
Cav1.2, IC50: 7.1 μM
     
Calcicludine  
L-type calcium channel, IC50: 88 nM
     
(+)-Niguldipine  
L-type calcium channel, Ki: 85 pM
     
Elgodipine  
L-type calcium channel, IC50: 2.3 nM
 
T-type calcium channel, IC50: 32 nM
 
Norverapamil-d7  
L-type calcium channel
     
Ginsenoside Rd (Standard)  
L-type calcium channel
     
Wy 27569        
Calcium Channel
Cav 2.2/3.2 blocker 1
CaV2.2, IC50: 78 μM
   
Cav3.2, IC50: 80 μM
 
sFTX-3.3
N-type calcium channel, IC50: 0.70 mM
 
P/Q-type calcium channel, IC50: 0.24 mM
   
5-Hydroxyindole (Standard)  
L-type calcium channel
     
Norverapamil-d7 hydrochloride  
L-type calcium channel
      98.77%
COX-2/CaV2.2-IN-1
CaV2.2, IC50: 0.29 μM
       
CPU-228  
L-type calcium channel
     
PD 175069
N-type calcium channel, IC50: 0.32 μM
       
Cavα2δ1&NET-IN-3        
Calcium Channel
α-Obscurine derivative-1      
CaV3.1, IC50: 0.19 μM
 
Aladorian sodium        
Calcium Channel
UR 8225  
L-type calcium channel
     
Cav 3.2 inhibitor 3      
Cav3.2, IC50: 0.1534 μM
 
Huwentoxin XVI
N-type calcium channel
       
Landiolol  
L-type calcium channel
     
HM12  
Cav1.2
 
Cav3.2
 
Multi-kinase-IN-10  
CaV1.1, IC50: 26.67 μM
     
ω-Hexatoxin-Hv1a  
L-type calcium channel
     
LY393615    
P/Q-type calcium channel, IC50: 4 μM
   
T-Type calcium channel inhibitor 2      
CaV3.1, IC50: 31.0 μM
Cav3.2, IC50: 83.1 μM
CaV3.3, IC50: 69.3 μM
 
GW7845  
L-type calcium channel
     
Lomerizine  
L-type calcium channel
     
GTx1-15        
Calcium Channel
Calciseptine TFA  
Cav1.2, IC50: 92 nM
     
Diltiazem malate  
L-type calcium channel
     
NIP 142  
L-type calcium channel
 
T-type calcium channel
 
KTt-45      
T-type calcium channel
 
Trimebutine-d3 hydrochloride  
L-type calcium channel
     
Diltiazem hydrochloride (Standard)  
L-type calcium channel
     
AT1R antagonist 3  
Cav1.2, Ki: 0.57 μM
     
Trimebutine-d5 fumarate  
L-type calcium channel
     
Efonidipine hydrochloride monoethanolate (Standard)  
L-type calcium channel, IC50: 1.8 nM
 
T-type calcium channel, IC50: 350 nM
 
Trimebutine maleate (Standard)  
L-type calcium channel
     
Calciseptine  
Cav1.2, IC50: 92 nM
     
Cav 3.1 blocker 1      
CaV3.1, IC50: 160 nM
Cav3.2, IC50: 5000 nM
CaV3.3, IC50: >10000 nM
CaV 1.2, IC50: >10000 nM
 
Landiolol hydrochloride (Standard)  
L-type calcium channel
     
Efonidipine hydrochloride  
L-type calcium channel, IC50: 1.8 nM
 
T-type calcium channel, IC50: 350 nM
 
8-Br-7-CH-cADPR        
Calcium Channel
Triphenylethylene  
L-type calcium channel
      99.86%
ABT-639 hydrochloride      
T-type calcium channel
 
Nefiracetam (Standard)
N-type calcium channel
L-type calcium channel
     
Trimebutine (Standard)  
L-type calcium channel
     
Norverapamil  
L-type calcium channel